Accuray Incorporated (ARAY) vs HeartBeam, Inc. (BEAT)

A side-by-side comparison of Accuray Incorporated and HeartBeam, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

ARAY

Accuray Incorporated

$33M

$0.28HealthcareDelayed quote: Oct 6, 2026, 2:59 PM EDT

BEAT

HeartBeam, Inc.

$34M

$0.61HealthcareDelayed quote: Oct 6, 2026, 3:00 PM EDT

Total return — ARAY vs BEAT

growth of $100 · dividends reinvested · last 5y

ARAY -94.7% (-44.5%/yr)BEAT -86.1% (-32.6%/yr)BEAT compounded faster over this window

ARAY BEAT

ARAY vs BEAT: by the numbers

•BEAT is the larger company ($34M vs $33M market cap).
•Both run net losses; BEAT's is the smaller (0.00% vs -12.24% net margin).

Metrics side by side

Valuation

Metric	ARAY	BEAT
P/S ratio	0.08	N/A
P/B ratio	0.79	4.16

Profitability

Metric	ARAY	BEAT
Gross margin	27.73%	0.00%
Operating margin	-6.58%	0.00%
Net margin	-12.24%	0.00%
ROE	-117.97%	-248.21%
ROIC	-10.09%	-249.58%

Growth (annualized)

Metric	ARAY	BEAT
Revenue CAGR (5Y)	0.28%	N/A
Total return CAGR (5Y)	-39.94%	N/A

Go deeper

Full ARAY analysis Full BEAT analysis Interactive comparison tool

Dig into the metrics

Accuray ROE HeartBeam ROE Accuray operating margin HeartBeam operating margin Accuray revenue growth HeartBeam revenue growth Accuray free cash flow HeartBeam free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.